Literature DB >> 11418729

Surfactant therapy for hyaline membrane disease: the Chandigarh experience.

A Narang1, P Kumar, S Dutta, R Kumar.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11418729

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN： 0019-6061            Impact factor:   1.411


× No keyword cloud information.
  6 in total

Review 1.  Changing trends in the management of respiratory distress syndrome (RDS).

Authors:  Praveen Kumar; P S Sandesh Kiran
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

2.  A new clinical respiratory distress score for surfactant therapy in preterm infants with respiratory distress.

Authors:  Debasish Nanda; Sushma Nangia; Anu Thukral; C P Yadav
Journal:  Eur J Pediatr       Date:  2019-12-18       Impact factor: 3.183

3.  Role of prophylactic surfactant in preterm infants.

Authors:  Daljit Singh; K S Rana; Sheila Mathai
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Continuous positive airway pressure for spontaneously breathing premature infants with respiratory distress syndrome.

Authors:  Ashok Saxena; R K Thapar; Vishal Sondhi; Parijat Chandra
Journal:  Indian J Pediatr       Date:  2012-03-07       Impact factor: 1.967

5.  Treatment Patterns and Clinical Outcomes in Neonates Diagnosed With Respiratory Distress Syndrome in a Low-Income Country: A Report From Bangladesh.

Authors:  Richard M Hubbard; Kamal M Choudhury; Grace Lim
Journal:  Anesth Analg       Date:  2018-05       Impact factor: 5.108

Review 6.  Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.

Authors:  M J Sankar; N Gupta; K Jain; R Agarwal; V K Paul
Journal:  J Perinatol       Date:  2016-05       Impact factor: 2.521
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.